Prednisone/Prednisolone
Sponsors
Pfizer, Cougar Biotechnology, Inc., Hoffmann-La Roche, Organon and Co, Bayer
Conditions
Advanced Solid TumorAsthmaB-Cell LymphomaChronic Lymphocytic LymphomaDiffuse Large B-cell Lymphoma (DLBCL)Follicular LymphomaFollicular Lymphoma (FL)Generalized Myasthenia Gravis
Phase 1
Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies
CompletedNCT04599634
Start: 2021-12-16End: 2024-06-20Updated: 2025-02-04
M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)
Active, not recruitingNCT06421935
Start: 2024-08-07End: 2027-02-22Target: 141Updated: 2026-03-24
Phase 2
Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)
Active, not recruitingNCT03407144
Start: 2018-04-09End: 2026-11-06Target: 340Updated: 2026-02-19
A Trial of the Efficacy and Safety of Izokibep in the Treatment of Non-anterior Uveitis
CompletedNCT04706741
Start: 2022-01-06End: 2022-11-14Updated: 2024-02-12
Phase 3
Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)
TerminatedNCT00562965
Start: 2007-11-30End: 2011-04-30Updated: 2018-01-09
Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
CompletedNCT00638690
Start: 2008-05-31End: 2012-10-31Updated: 2014-04-30
A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma
CompletedNCT01200758
Start: 2011-02-15End: 2017-10-31Updated: 2018-11-27
Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms
CompletedNCT02043678
Start: 2014-03-30End: 2024-02-08Updated: 2025-02-19
Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris
TerminatedNCT02613910
Start: 2015-12-23End: 2016-03-23Updated: 2017-06-14
Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)
CompletedNCT02741271
Start: 2016-05-11End: 2017-12-04Updated: 2024-05-16
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
CompletedNCT03072238
Start: 2017-06-30End: 2024-04-24Updated: 2025-06-06
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
RecruitingNCT06091254
Start: 2023-12-12End: 2029-11-03Target: 822Updated: 2026-03-11
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Active, not recruitingNCT06091865
Start: 2023-12-13End: 2029-09-02Target: 904Updated: 2026-02-05
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
RecruitingNCT06911502
Start: 2025-07-28End: 2030-07-31Target: 400Updated: 2025-12-05
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Not yet recruitingNCT07365995
Start: 2026-03-01End: 2031-02-01Target: 736Updated: 2026-01-26
Phase 4
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241)
CompletedNCT01471340
Start: 2012-01-09End: 2016-11-30Updated: 2024-05-23
A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
Not yet recruitingNCT07221838
Start: 2026-02-27End: 2027-08-27Target: 75Updated: 2026-03-03
Unknown Phase
Related Papers
47 more papers not shown